There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K40/42
Subcategories
This category has the following 21 subcategories, out of 21 total.
A
B
C
D
E
G
J
K
M
P
R
W
Y
Pages in category "A61K40/42"
The following 16 pages are in this category, out of 16 total.
1
- 18834037. NATURAL KILLER T-CELLS AND METHODS OF USING THE SAME (The University of North Carolina at Chapel Hill)
- 18883386. USE OF A PIKFYVE INHIBITOR IN COMBINATION WITH IMMUNOTHERAPY (The Regents of the University of Michigan)
- 18930893. CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18931863. MODIFIED IMMUNE CELLS AND METHODS FOR USE THEREOF (The General Hospital Corporation)
- 18951341. USE OF HISTONE MODIFIERS TO REPROGRAM EFFECTOR T CELLS (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
- 19000208. ENGINEERED ANTIGEN PRESENTING CELLS AND USES THEREOF (Massachusetts Institute of Technology)
- 19015063. BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD20 and CD19 (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
B
T
- The regents of the university of california (20250136659). CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF
- The regents of the university of california (20250144144). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD20 and CD19
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on May 1st, 2025
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on May 8th, 2025